Paul Woitach

Paul Woitach is an accomplished professional with extensive experience in the pharmaceutical and life sciences sectors. Currently serving as Managing Partner at Pharmaceutical Advisors LLC since 2005, Paul specializes in aiding clients with drug development and commercialization programs. Paul also holds a position on the Board of Directors at the Camille and Henry Dreyfus Foundation, Inc., where Paul chairs the Finance & Audit, Compensation, and Scientific Affairs Committees, promoting advancements in chemistry and related sciences. Paul has contributed to various organizations including the New Jersey Bioscience Center as an Advisory Board member and previously as a Board Member at Hackensack University Medical Center Life Science Institute. In previous roles, Paul has held leadership positions such as President & CEO at Immunogenetics Inc. and IGI, Inc., President of Solutia Pharmaceutical Advisors, and Vice President & General Manager at Mettler Toledo, among others. Paul earned an MBA from the University of Rochester - Simon Business School and a BA in Economics from the University of Rochester.